Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

OS THERAPIES INCORPORATED (OSTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

OS THERAPIES INCORPORATED (OSTX), most recent 12 months reported: net loss $39.37M, free cash flow -$14.7M. Latest balance sheet on file: liquid cash $205.03K. From SEC filings. Others in Pharmaceutical Preparations: OMEROS CORP · ONCOLYTICS BIOTECH INC. · ORIC PHARMACEUTICALS, INC. · Oruka Therapeutics, Inc. · Oncotelic Therapeutics, Inc. · Processa Pharmaceuticals, Inc. · PDS Biotechnology Corporation · PEPGEN INC.

Stock screener

Watchlist